LifeScan

LifeScan is a global leader in glucose monitoring and diabetes management, serving more than 20 million consumers worldwide through its OneTouch® brand. The company develops and markets blood glucose meters, continuous glucose monitoring systems, mobile applications, and related digital health solutions for diabetes self-management. Product lines include the OneTouch Verio Flex® blood glucose meter paired with the OneTouch Reveal® mobile application, which provides real-world evidence of improved glycemic control. LifeScan recently announced a transformational partnership with i-SENS to launch a OneTouch® Continuous Glucose Monitoring System, expanding its portfolio into CGM technology. The company emphasizes patient-centric digital solutions and clinical validation; multiple peer-reviewed studies document clinically significant improvements in glycemic control across diverse patient populations using LifeScan's smart meters and mobile apps. LifeScan serves both individual consumers and healthcare systems, with a focus on Type 1 and Type 2 diabetes management. The company maintains a global presence and was recently recognized by the Princess Royal Training Awards (2024). Operations include manufacturing, digital partnerships, customer support, and clinical research capabilities. LifeScan emerged from financial restructuring in 2025 with renewed operational focus on innovation and market expansion.